Julie Clark
Chief Tech/Sci/R&D Officer at OPTHEA LIMITED
Profile
Julie Clark is currently the Senior Vice President-Clinical Development at Opthea Ltd.
She previously worked as an Associate Director-Medical affairs at Regeneron Pharmaceuticals, Inc. from 2011 to 2012.
Dr. Clark also held positions as a Medical Director at Novartis Corp., Thrombogenics, Inc., and Adverum Biotechnologies, Inc. She was also the Chief Medical Officer at Adverum Biotechnologies, Inc. Additionally, Dr. Clark served as the Vice President-Clinical Development at IVERIC bio, Inc. Dr. Clark received her undergraduate and doctorate degrees from Wake Forest School of Medicine and her undergraduate degree from Wake Forest University.
She also obtained a graduate degree from The Johns Hopkins University.
Julie Clark active positions
| Companies | Position | Start |
|---|---|---|
| OPTHEA LIMITED | Chief Tech/Sci/R&D Officer | 01/02/2024 |
Former positions of Julie Clark
| Companies | Position | End |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 22/10/2021 |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2012 |
| IVERIC BIO, INC. | Corporate Officer/Principal | - |
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The private company is based in New York, NY. | Chief Tech/Sci/R&D Officer | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Training of Julie Clark
| Wake Forest School of Medicine | Doctorate Degree |
| The Johns Hopkins University | Graduate Degree |
| Wake Forest University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| OPTHEA LIMITED | Health Technology |
| Private companies | 3 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The private company is based in New York, NY. | Commercial Services |
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
- Stock Market
- Insiders
- Julie Clark
